Exonate – University of Bristol Enterprise Fund I investment

We are delighted to announce that the University of Bristol Enterprise Fund I, managed by Parkwalk, has invested in Exonate. Exonate are developing a novel approach to modulating new vessel growth.  By controlling the balance of two contrasting forms of a… Read More